XLY News 66.95 09/24/2014 06:02:06 Consumer Discret Select Sector

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Consumer Discret Select Sector SPDR (XLY) 66.95 $XLY

What's Your Favorite Sector Bet? - Real Time Insight
Kevin Cook - Zacks Investment Research - Tue Sep 09, 7:24AM CDT
Assume my S&P 2250 prediction is on the way and tell me where you put money

Consumer Spending Drives Stock Market to Record Highs
at The Street - Thu Aug 28, 9:58AM CDT
Improved consumer spending has underlined the stock market's rally, signaling more gains ahead

Which Sectors Are You Betting On? - Real Time Insight
Todd Bunton - ZACKS - Wed Aug 13, 3:35PM CDT
Which sectors do you think will outperform or underperform throughout the rest of 2014?

Uptick in Consumer Spending Could Mean a Second-Half Market Rally
at The Street - Mon Aug 11, 10:47AM CDT
The consumer discretionary sector has outperformed consumer staples companies over the past few months.

Sideways Stocks = Sideways Consumers? - Real Time Insight
John Blank - Zacks Investment Research - Fri Aug 08, 7:46AM CDT
Are Range-Bound Stock Markets Slowing Consumer Growth?

Disney Posts Solid Earnings: 3 ETFs to Watch - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Aug 07, 5:00AM CDT
After Disney's earnings, these Consumer Discretionary ETFs will be in focus in the coming days.

How Many More 100-Point-Swing Days on the DJIA Can You Take?
at The Street - Mon Jul 28, 4:43PM CDT
The stock indexes fluctuated wildly on Monday as the hedge funds trading the S&P between the daily trading range.

China Food Safety and Poor Earnings Put These Consumer ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 24, 11:00AM CDT
Thanks to more issues for Yum and McDonalds in China, these consumer ETFs could face some rocky trading ahead.

'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.

Could Earnings Prove Consumer Goods Pessimists Wrong?
Joseph Hogue, The Motley Fool - Motley Fool - Thu Jul 10, 6:00PM CDT
The consumer discretionary group is the only sector that posted a loss for the first half of the year, as it trailed the S&P 500 by more than 6%. Poor consumer spending in the first quarter drove earnings expectations lower and analysts largely...

Utilities, Energy, Health Care Are the ETFs to Beat This Year
at The Street - Thu Jul 03, 10:10AM CDT
I track 11 exchange-traded funds, and the best year-to-date performer is utilities, while health care set an all-time high on Wednesday.

'Fast Money' Recap: Let Your Winning Trades Keep Running
at The Street - Wed Jul 02, 4:00AM CDT
The trading panel discussed yet another closing high for the S&P 500 and DJIA plus what they are buying and selling.

This U.S. Stock Market Is Not Dealing in Reality as It Moves Higher
at The Street - Mon Jun 30, 4:32PM CDT
The stock market on Monday closed out the second quarter in mixed fashion. The DJIA is oversold while the Nasdaq is overbought.

A Stock Market Selloff With Some Volume and Power Behind It
at The Street - Tue Jun 24, 4:20PM CDT
The stock indexes closed down on Tuesday after an intraday turn from the upside. The downside volume was big in comparison to the upside volume for the past month.

The Zacks Analyst Blog HighlightsowerShares Dynamic Building & Construction, Consumer Discretionary Select Sector SPDR Fund, Industrials/Producer Durables AlphaDEX Fund and SPDR S&P 500 ETF
PR Newswire - Tue Jun 24, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the PowerShares Dynamic Building & Construction (AMEXKB-Free Report), Consumer Discretionary Select Sector SPDR Fund (AMEX:XLY-Free Report), Industrials/Producer Durables AlphaDEX Fund (AMEX:FXR-Free Report) and SPDR S&P 500 ETF (AMEX:SPY-Free Report).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Biohaven's BHV-1530 Data Earns a Careful Investor Look

Updated Category News Views 19

Thirty heavily treated cancer patients can make a molecule look brilliant or merely lucky, and BHV-1530 is still living in that uncomfortable early-stage gap. Biohaven presented Phase 1 results at ENA 2026 that deserve real attention, particularly because the responses showed up in patients with few attractive remaining options. But this is not the moment to confuse a...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Yiwu Squishies Turn Viral Demand Into Factory Backlogs Worldwide

Updated Category News Views 21

A pizza-shaped stress toy booking more than one million units is the sort of detail that makes a jaded market watcher sit up before rolling his eyes at the word “viral.” Yiwu’s squishy-toy surge appears to have moved beyond a few social-media impulses and into actual factory scheduling, repeat purchase orders and supermarket procurement. That is meaningful. It is...

Continue Reading
Tongwei's 846 MW Romania Deal Tests Solar Supply Scale

Updated Category News Views 74

Eight hundred forty-six megawatts of panels do not quietly roll out the factory gate. Tongwei’s supply agreement with Rezolv Energy for Romania’s Dama Solar project is a hefty piece of utility-scale solar business, and the first truckload has already left Tongwei’s Nantong facility. That matters more than another polished signing-ceremony photo: equipment is moving,...

Continue Reading
NVE Revenue Pull-Forward Raises Hard Investor Questions

Updated Category News Views 50

A Quarter Can Look Great Until It Doesn’t NVE investors got a nasty lesson in revenue timing, the sort that makes even old hands check the fine print twice. On July 22, 2026, the company reported sequential revenue growth of 43% and net-income growth of 23%. The next trading day, shares vaulted $47.53, or 54%. Then came October, and the floor gave way: NVE reported that...

Continue Reading
Goosehead Restatement Puts Accounting Trust on Trial

Updated Category News Views 87

A filing delay can be irritating; a multi-year no-rely warning is something uglier. Goosehead Insurance told investors on November 9, 2026, that it would not timely file its quarterly report for the period ended September 30 and that prior financial statements must be restated. That is not a garden-variety paperwork hiccup. It reaches back across fiscal 2023, 2024 and...

Continue Reading
Brightstar Picks Warsop for Its Next CEO Chapter Ahead

Updated Category News Views 31

A Handoff With Plenty Riding on the Rails A lottery supplier changing captains is not usually fireworks, but this one deserves a hard look. Brightstar Lottery has named Thomas Warsop to replace Vince Sadusky as chief executive officer and board member effective January 1, 2027. Sadusky is retiring from both posts on that date. The company is telegraphing an orderly baton...

Continue Reading
T. Rowe Price Expands Teams Across 12 Fund Strategies

Updated Category News Views 49

A Quiet Personnel Shift With Real Stakes Twelve strategy changes may sound like administrative wallpaper, but asset managers live and die by who makes the calls. T. Rowe Price is broadening portfolio-management teams across equity and fixed-income offerings while insisting that each strategy's philosophy, process, and risk limits remain intact. Fine. That is the stated...

Continue Reading
Abbe Lane Estate Puts Jewelry Demand on Full Display

Updated Category News Views 101

Glamour Is Walking Back Into the Auction Room Abbe Lane’s jewelry is not being offered as a vague nostalgia exercise; it is arriving with dates, a setting, and a clear split between two December sales. John Moran Auctioneers will lead with The Estate of Abbe Lane on Wednesday, December 9, 2026, at 10:00 a.m. PST, then follow with its Jewelry & Watches auction on...

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 217

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading

Top 5 Most Recently Viewed Articles

commercetools Compilations: Innovations Driving Digital Growth

Updated Category News Views 177

Exciting Launch of commercetools Compilations commercetools has unveiled Compilations, a semi-annual showcase that highlights more than 50 product enhancements, demonstrating the organization’s dedication to innovation and improved customer experiences for users of the commercetools Platform. With over 13,000 deployments and 200 releases, this initiative significantly...

Continue Reading
Join the Class Action Against Red Cat Holdings, Inc. Today

Updated Category News Views 185

Understanding the Class Action Against Red Cat Holdings, Inc. Red Cat Holdings, Inc. is currently under the spotlight due to a class action securities lawsuit filed by the law firm Levi & Korsinsky, LLP. The firm is reaching out to investors who believe they have incurred losses due to the alleged securities fraud that transpired between a specified period. If you have...

Continue Reading
GRAIL Initiates Patient Testing with Innovative Blood Test for Lung Cancer

Updated Category News Views 127

GRAIL Announces Milestone in Lung Cancer Detection GRAIL, Inc. (Nasdaq: GRAL), a pioneering healthcare firm focused on early cancer detection, has achieved a significant milestone by announcing that the first patient has been assessed for eligibility through its innovative non-small cell lung cancer (NSCLC) ctDNA Assay. This groundbreaking development occurs within the...

Continue Reading
Neurocrine Biosciences Enhances Collaboration with Takeda

Updated Category News Views 197

Neurocrine Biosciences Enhances Collaboration with Takeda Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has recently announced an amendment to strengthen the strategic collaboration with Takeda. This partnership focuses on the development and commercialization of osavampator, an innovative therapeutic candidate that holds promise for patients suffering from major depressive...

Continue Reading
LivaNova Prepares to Reveal 2024 Year-End Financials

Updated Category News Views 94

LivaNova's Upcoming Financial Announcement LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, is gearing up for an important event. The company will hold a conference call in which they will discuss their financial results from the fourth quarter as well as the entire year of 2024. This event is slated for a Tuesday afternoon and is expected...

Continue Reading